These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 19589888)

  • 1. Soluble receptor for advanced glycation end products: a new biomarker in diagnosis and prognosis of chronic inflammatory diseases.
    Maillard-Lefebvre H; Boulanger E; Daroux M; Gaxatte C; Hudson BI; Lambert M
    Rheumatology (Oxford); 2009 Oct; 48(10):1190-6. PubMed ID: 19589888
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Serum levels of soluble form of receptor for advanced glycation end products (sRAGE) are positively associated with circulating AGEs and soluble form of VCAM-1 in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Microvasc Res; 2008 May; 76(1):52-6. PubMed ID: 18474381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased levels of soluble receptor for advanced glycation end products in patients with rheumatoid arthritis indicating deficient inflammatory control.
    Pullerits R; Bokarewa M; Dahlberg L; Tarkowski A
    Arthritis Res Ther; 2005; 7(4):R817-24. PubMed ID: 15987483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute Kawasaki disease is associated with reverse regulation of soluble receptor for advance glycation end products and its proinflammatory ligand S100A12.
    Wittkowski H; Hirono K; Ichida F; Vogl T; Ye F; Yanlin X; Saito K; Uese K; Miyawaki T; Viemann D; Roth J; Foell D
    Arthritis Rheum; 2007 Dec; 56(12):4174-81. PubMed ID: 18050248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Advanced glycation end product receptor-mediated cellular dysfunction.
    Bierhaus A; Humpert PM; Stern DM; Arnold B; Nawroth PP
    Ann N Y Acad Sci; 2005 Jun; 1043():676-80. PubMed ID: 16037292
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Positive association between serum levels of advanced glycation end products and the soluble form of receptor for advanced glycation end products in nondiabetic subjects.
    Yamagishi S; Adachi H; Nakamura K; Matsui T; Jinnouchi Y; Takenaka K; Takeuchi M; Enomoto M; Furuki K; Hino A; Shigeto Y; Imaizumi T
    Metabolism; 2006 Sep; 55(9):1227-31. PubMed ID: 16919543
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Receptor for advanced glycation end products--soluble form and gene polymorphisms in chronic haemodialysis patients.
    Kalousová M; Jáchymová M; Mestek O; Hodková M; Kazderová M; Tesar V; Zima T
    Nephrol Dial Transplant; 2007 Jul; 22(7):2020-6. PubMed ID: 17347281
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAGE: therapeutic target and biomarker of the inflammatory response--the evidence mounts.
    Ramasamy R; Yan SF; Schmidt AM
    J Leukoc Biol; 2009 Sep; 86(3):505-12. PubMed ID: 19477910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating advanced glycation end products (AGEs) and soluble form of receptor for AGEs (sRAGE) are independent determinants of serum monocyte chemoattractant protein-1 (MCP-1) levels in patients with type 2 diabetes.
    Nakamura K; Yamagishi S; Adachi H; Matsui T; Kurita-Nakamura Y; Takeuchi M; Inoue H; Imaizumi T
    Diabetes Metab Res Rev; 2008 Feb; 24(2):109-14. PubMed ID: 17694504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Receptor for advanced glycation end products (RAGE) in vascular and inflammatory diseases.
    Mahajan N; Dhawan V
    Int J Cardiol; 2013 Oct; 168(3):1788-94. PubMed ID: 23722052
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Soluble receptor for advanced glycation end products triggers a proinflammatory cytokine cascade via beta2 integrin Mac-1.
    Pullerits R; Brisslert M; Jonsson IM; Tarkowski A
    Arthritis Rheum; 2006 Dec; 54(12):3898-907. PubMed ID: 17133598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The AGE/RAGE axis in diabetes-accelerated atherosclerosis.
    Jandeleit-Dahm K; Watson A; Soro-Paavonen A
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):329-34. PubMed ID: 18290873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Pro12Ala polymorphism of peroxisome proliferator-activated receptor-gamma2 gene is associated with plasma levels of soluble RAGE (Receptor for Advanced Glycation Endproducts) and the presence of peripheral arterial disease.
    Catalano M; Cortelazzo A; Santi R; Contino L; Demicheli M; Yilmaz Y; Zorzetto M; Campo I; Lanati N; Emanuele E
    Clin Biochem; 2008 Aug; 41(12):981-5. PubMed ID: 18538667
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Receptor for Advanced Glycation Endproducts (RAGE): a formidable force in the pathogenesis of the cardiovascular complications of diabetes & aging.
    Yan SF; D'Agati V; Schmidt AM; Ramasamy R
    Curr Mol Med; 2007 Dec; 7(8):699-710. PubMed ID: 18331228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of feto-maternal infection/inflammation by the soluble receptor for advanced glycation end products (sRAGE): results of a pilot study.
    Hájek Z; Germanová A; Koucký M; Zima T; Kopecký P; Vítkova M; Parízek A; Kalousová M
    J Perinat Med; 2008; 36(5):399-404. PubMed ID: 18771410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Circulating soluble receptor for advanced glycation end products is inversely associated with body mass index and waist/hip ratio in the general population.
    Norata GD; Garlaschelli K; Grigore L; Tibolla G; Raselli S; Redaelli L; Buccianti G; Catapano AL
    Nutr Metab Cardiovasc Dis; 2009 Feb; 19(2):129-34. PubMed ID: 18595673
    [TBL] [Abstract][Full Text] [Related]  

  • 17. RAGE: a novel biological and genetic marker for vascular disease.
    Kalea AZ; Schmidt AM; Hudson BI
    Clin Sci (Lond); 2009 Apr; 116(8):621-37. PubMed ID: 19275767
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Soluble receptor for advanced glycation end products in patients with decreased renal function.
    Kalousová M; Hodková M; Kazderová M; Fialová J; Tesar V; Dusilová-Sulková S; Zima T
    Am J Kidney Dis; 2006 Mar; 47(3):406-11. PubMed ID: 16490618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Receptor for advanced glycation end products (RAGE)--soluble form (sRAGE) and gene polymorphisms in patients with breast cancer.
    Tesarová P; Kalousová M; Jáchymová M; Mestek O; Petruzelka L; Zima T
    Cancer Invest; 2007 Dec; 25(8):720-5. PubMed ID: 18058469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Receptor for advanced glycation end products and its ligands: a journey from the complications of diabetes to its pathogenesis.
    Kim W; Hudson BI; Moser B; Guo J; Rong LL; Lu Y; Qu W; Lalla E; Lerner S; Chen Y; Yan SS; D'Agati V; Naka Y; Ramasamy R; Herold K; Yan SF; Schmidt AM
    Ann N Y Acad Sci; 2005 Jun; 1043():553-61. PubMed ID: 16037278
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.